Skandinaviska Enskilda Banken (SEB)’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
IA
MCI
HNB
Skandinaviska Enskilda Banken (SEB)'s AMED Position: Q3 2025 in Review
Skandinaviska Enskilda Banken (SEB) sold out of Amedisys (AMED) in Q3 2025, closing a stake of 38,186 shares — an estimated $3.76M sold.
Skandinaviska Enskilda Banken (SEB) first reported a position in AMED in Q4 2020 and held it in 12 quarters. The position peaked at $3.76M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Skandinaviska Enskilda Banken (SEB) reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Skandinaviska Enskilda Banken (SEB) sold 38,186 Amedisys shares in Q3 2025, an estimated $3.76M.
- Skandinaviska Enskilda Banken (SEB) first reported a position in Amedisys in Q4 2020 and held it in 12 quarters.
- Skandinaviska Enskilda Banken (SEB)'s Amedisys position peaked at $3.76M in Q2 2025.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.